• Explore /
  • Poster
  • / Candidate biomarker analyses in gastric or gastro-esophageal junction carcinoma: REGARD trial of single-agent ramucirumab (RAM) vs. placebo (PL).

Candidate biomarker analyses in gastric or gastro-esophageal junction carcinoma: REGARD trial of single-agent ramucirumab (RAM) vs. placebo (PL).

Abstract Poster

Authors

null

Charles S. Fuchs

Dana-Farber Cancer Institute, Boston, MA

Charles S. Fuchs , Josep Tabernero , Jiri Tomasek , Ian Chau , Bohuslav Melichar , Howard Safran , Mustapha Ali Tehfe , Filip Dumitru , Eldar Topuzov , Luis Schlittler , Anghel Adrian Udrea , William Campbell , Stephen Brincat , Michael Emig , Symantha A. Melemed , Rebecca R. Hozak , David Ferry , William Caldwell , Jaffer A. Ajani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT00917384

Citation

J Clin Oncol 33, 2015 (suppl; abstr 4029)

DOI

10.1200/jco.2015.33.15_suppl.4029

Abstract #

4029

Poster Bd #

138

Abstract Disclosures

Similar Posters

First Author: Kazuto Nishio

First Author: Alessandra Raimondi

First Author: Naoki Takahashi

First Author: Atsushi Ishiguro